STOCK TITAN

Bioelectronics Corp - BIEL STOCK NEWS

Welcome to our dedicated news page for Bioelectronics (Ticker: BIEL), a resource for investors and traders seeking the latest updates and insights on Bioelectronics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bioelectronics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bioelectronics's position in the market.

Rhea-AI Summary
BioElectronics announces positive results from a study on its FDA-cleared PSWT device for treating osteoarthritis in dogs. 96% of treated dogs showed improvement in passive range of motion and behavioral changes compared to the placebo group. The study, published in Veterinary Medicine & Science, highlights the potential of BioElectronics' technology in enhancing the quality of life for canines with OA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BioElectronics Corporation announces positive results in a study on treating phantom and residual limb pain with its pulsed shortwave therapy device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BioElectronics Corporation provides an update on clinical trial progress and potential legal action against MundiPharma. The company discusses ongoing clinical trials, completed studies under peer review, manufacturing improvements, and sales activities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
BioElectronics Corp. (OTC: BIEL) has seen good progress on the research side, with positive results from various clinical studies and a new product design. However, the sales front has been more mixed, with new distributors in some regions but failed talks with a major distributor in Asia and the CIS countries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
Bioelectronics Corp

OTC:BIEL

BIEL Rankings

BIEL Stock Data

7.41M
0%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States
Frederick

About BIEL

bioelectronics corporation, headquartered in frederick, maryland, usa, is an award winning developer and manufacturer of innovative consumer medical devices that are designed to treat both acute and chronic pain. these medical devices are a pioneering advancement of pulsed shortwave therapy. traditional pulsed shortwave therapies are clinically proven, effective, safe and have been used for decades by physicians and physiotherapists. advances in microelectronics have made it possible to deliver clinically proven and superior extended duration therapy in a small, convenient and economical medical device. bioelectroceuticals have an improved pulse rate and lower power level to provide superior extended duration treatments and safe home use therapy to lower the cost of care. our products cover a wide range of markets including the actipatch® for musculoskeletal pain, smart insole™ for foot care, allay® for menstrual pain, recoveryrx® for chronic wounds and postoperative recovery and healf